The HealthTech Activator maintains a selection of links to key podcast episodes covering topics relevant to healthtech commercialisation. Contact us if you know of any healthtech commercialisation podcasts that you think should be included here.
Join MTPConnect for their inaugural seminar on 'Australian Women in Life Sciences Leadership - a Global Perspective' held during BIO 2023 in Boston. Hear from two of the guest speakers, Dr Iris Depaz from Sanofi, and Sibylle Hauser from California Life Sciences, about their career trajectories and what Women’s Leadership means to them.
Join HiNZ to hear from Hira programme director Ray Delany, who discusses the vision for Hira, the programme reset, achievements so far, and the future of electronic and personal health records in Aotearoa New Zealand.
The "Consolidated Appropriations Act of 2023" (more commonly referred to as the Omnibus Act) was passed and signed into law on December 29th, 2022. This amendment to the Food and Drug Cosmetic Act has expanded the scope of the FDA beyond just "safety and efficacy" to include the cybersecurity of medical devices. Join the Global Medical Device podcast to learn more from experts in the field.
Join MTPConnect for this episode as they tap into an international perspective on the digital health sector and the business of healthcare. Lisa Suennen is a US-based entrepreneur and industry advisor. After thirty years in healthcare and seeing little progress in efficiency and optimisation of care, she moved into the digital health space, working as a venture capital investor, speaker and writer.
If you’re a startup founder, you may be looking to scale internationally, and just like everything else along the startup journey, moving into a new market can be rather challenging. As such, its quite beneficial to have someone who’s done it before be your mentor. In this episode, we learn more about how New Zealand Trade & Enterprise is making it easier for startups to bring their business to other parts of the world.
How does a quality management system (QMS) and regulatory factors impact fundraising, pre-money valuation, market access, and commercialization for medical device companies? In this episode of the Global Medical Device Podcast, Etienne Nichols talks to Cristiano Fontana, founder and CEO of ThreeBridges.
Alcidion’s chief medical officer Malcolm Pradhan discusses the concept of virtual hospitals and how they are being used in response to Covid-19 to increase capacity in the health system. Also, how to scale virtual models of care, identify suitable patients and ensure a return on investment.
In this episode, we take you to the launch of our new report into Australia’s Clinical Trials sector held on International Clinical Trials Day in Melbourne. MTPConnect brought together a panel of thought leaders to discuss the importance of clinical trials...
In this episode, we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. You will hear from Colin Denver, CEO of SpeeDx, an Australian diagnostics company developing tests for infectious diseases including COVID-19.
Navigating the ever-changing sea of medtech reimbursement is never easy, particularly with the recent swings in policies pertaining to breakthrough devices. Host Geoff Pardo moderates a panel interview with three medtech reimbursement experts to look at strategies for obtaining reimbursement coding, coverage, and payment.
Cash-flow challenges and team tensions are just two of the issues a fledgling business can face. Learn from them and move on, say seasoned entrepreneurs.
A successful entrepreneur needs to quickly develop a strategy to scale up their company, transfer skills to colleagues and shape a team.
Scientist-turned-lawyer Tamsen Valoir outlines a key step on the road to commercializing your research.
In this episode we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. You will hear from Dr Nina Webster, the Managing Director & CEO of Dimerix Limited who shares the highs and lows of forming relationships and doing deals online in the age of COVID-19.
Seasoned science entrepreneurs tell Adam Levy how to take the daunting first steps to commercializing your research.
Hear from Boston-based CIMIT Chief Operating Officer Dr John Collins, Health Horizon Co-Founder & CEO Marcus Dawe and OncoRes Medical MD & CEO Dr Kath Giles to discuss how to best to navigate the pathways to commercialising health innovations...
Hear from MTPConnect’s MD & CEO Dr Dan Grant, our MC Director Stakeholder Engagement NSW Dr Duncan Macinnis, AustCyber CEO Michelle Price, Perx Health’s Co-Founder & CEO Hugo Rourke and Forticode’s CEO Tony Smales discuss cyber safety and security in relation to the MTP sector.
MTPConnect hosted Medical Alley Association’s VP Intelligence Frank Jaskulke for our first Seminar Series around Australia. The podcast team spoke to Frank after he completed his tour of Queensland, New South Wales and Western Australia, to find out how prepared Australian medtech companies are to break into the United States...
For this edition of the MTPConnect Podcast, we speak to Arthur Ong, Head of Product Management at Curve Tomorrow, the award winning digital health and technology company on a mission to impact 1 billion lives. We discuss digital health trends, their work with the Murdoch Children’s Research Institute & AFL to create the HeadCheck app for concussion management, pitching digital health innovations and more.
For medtech, pharma and digital health innovators, cracking the US market can make all the difference for a business venture.It’s equally parts lucrative and challenging. We invited Frank Jaskulke, VP Intelligence at the Medical Alley Association in Minnesota, and our very own GM Stakeholder Engagement Dr Alfredo Martinez-Coll into the MTPConnect podcast studio to break down the do's and dont's of a US market entry strategy.
The HealthTech Activator (HTA) maintains this collection of third party podcasts of interest to those in the healthtech sector. The podcasts linked to on this page do not reflect the opinion of the HTA or Callaghan Innovation and neither the HTA nor Callaghan Innovation endorse the podcasts, their content or their authors.